Wednesday, September 16, 2020 6:14:22 PM
Lexaria Bioscience Corp (LXX.CN)
0.375 +0.025 (+7.14%) 09/16/20 [CNSX]
QUOTE OVERVIEW for Wed, Sep 16th, 2020Alerts Watch Help
Day Low
0.365
Day High
0.375
Open 0.375
Previous Close0.350
Volume19,950
Avg Vol41,593
Stochastic %K18.89%
Weighted Alpha-60.10
5-Day Change+0.005 (+1.35%)
52-Week Range0.310 - 0.990
since 09/16/19
Most Recent Stories
Lexaria Bioscience Supports Corporate Growth Initiatives by its Licensee, Cannadips CBD by the Boldt Runners Corporation
TheNewswire.ca - Wed Sep 16, 5:25AM CDT
(via TheNewswire)
LXX.CN : 0.375 (+7.14%)
Lexaria Bioscience Announces R&D Agreement With British American Tobacco
ACCESSWIRE - Mon Aug 31, 3:02PM CDT
KELOWNA, BC / ACCESSWIRE / August 31, 2020 / Lexaria Bioscience Corp. (OTCQX:LXRP)(CSE:LXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, announces that it has entered a...
LXX.CN : 0.375 (+7.14%)
Lexaria Bioscience to Present at the LD 500 Virtual Conference
ACCESSWIRE - Thu Aug 20, 6:17AM CDT
Company to discuss its Phase I R&D program with Altria Ventures Inc., for oral forms of nicotine delivery utilizing its patented DehydraTECH™ technology
LXRP : 0.2835 (+4.00%) LXX.CN : 0.375 (+7.14%)
Medical Marijuana Market 2020 Industry Size, Growth, Trends, Segments and Cost Structure Analysis Research Report 2028
AmericaNewsHour - Mon Aug 3, 7:25AM CDT
Research Nester published a report titled which delivers a detailed overview of the medical marijuana market in terms of market segmentation by end- user, by product, by application, and by region.
Lexaria Announces 2020 Annual and Special Meeting Results
TheNewswire.ca - Wed Jun 24, 5:15AM CDT
(via TheNewswire)
LXRP : 0.2835 (+4.00%) LXX.CN : 0.375 (+7.14%)
Lexaria Bioscience Applies for NIH Grant for COVID-19 Therapy Studies and Receives New Expanded Health Canada License
TheNewswire.ca - Thu Jun 18, 5:30AM CDT
(via TheNewswire)
LXRP : 0.2835 (+4.00%) LXX.CN : 0.375 (+7.14%)
Medical Marijuana Market To Grow During 2020-28 On Account Of Increasing Adult Patients With Chronic Diseases
AmericaNewsHour - Wed Jun 17, 6:52AM CDT
Research Nester published a report titled which delivers a detailed overview of the medical marijuana market in terms of market segmentation by end- user, by product, by application, and by region.
Marijuana Market Trends, Share, Size, Growth, Supply and Manufacturers Analysis Research Report 2025
AmericaNewsHour - Wed Jun 17, 3:38AM CDT
Global Marijuana Market was valued at USD 17.2 Billion in the year 2017. Global Marijuana Market is further estimated to grow at a CAGR of 22.9% from 2019 to reach USD 88.97 Billion by the year 2025. North...
Barchart Technical Opinion LXRP Lexaria Bioscience Corp.
The Barchart Technical Opinion rating is a 88% Sell with a Weakening short term outlook on maintaining the current direction.
The market is approaching oversold territory. Be watchful of a trend reversal.
Recent LEXX News
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/06/2024 11:00:40 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/01/2024 07:28:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:30:59 PM
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 02/16/2024 08:47:26 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 02/14/2024 07:20:50 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 05:00:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/30/2024 06:51:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/24/2024 07:12:07 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 01/24/2024 06:33:08 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 01/18/2024 07:38:18 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/12/2024 10:11:16 PM
- Lexaria Bioscience Corp. (NASDAQ: LEXX) Proprietary Drug-Delivery System Improves Way Molecules Enter Bloodstream • GlobeNewswire Inc. • 01/11/2024 01:30:00 PM
- Beyond Diabetes, a Blockbuster Horizon Beckons • InvestorsHub NewsWire • 01/10/2024 01:45:00 PM
- Lexaria Bioscience Corp. (NASDAQ: LEXX) Improves Delivery, Efficacy of GLP-1 Agonists Through Proprietary Drug-Delivery Platform • GlobeNewswire Inc. • 01/09/2024 01:30:00 PM
- Exciting New Cures Possible from GLP-1 Diabetes, Weight-Loss Drugs • InvestorsHub NewsWire • 01/08/2024 01:45:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/04/2024 10:07:45 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 11/30/2023 09:14:31 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 11/20/2023 10:16:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/03/2023 05:13:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/01/2023 05:45:34 PM
- Get Ready for Next Generation of Diabetes, Weight-Management Drugs • InvestorsHub NewsWire • 11/01/2023 12:45:00 PM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM
Avant Technologies Launches Advanced AI Supercomputing Network and Expansive Data Solutions • AVAI • Apr 23, 2024 8:00 AM
BestGrowthStocks.com Issues Comprehensive Analysis of Triller Merger with AGBA Group Holding Limited • AGBA • Apr 22, 2024 1:00 PM
Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • BLO • Apr 22, 2024 8:49 AM
Kona Gold Beverages, Inc. Prepares for First Production Run Set to Launch May 17, 2024 • KGKG • Apr 22, 2024 8:30 AM